• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酮色林对健康受试者的基础垂体前叶激素分泌无影响。

Ketanserin without effects on basal anterior pituitary hormone secretion in healthy subjects.

作者信息

Gordin A, Mustajoki P, Pelkonen R

出版信息

J Endocrinol Invest. 1985 Feb;8(1):73-5. doi: 10.1007/BF03350647.

DOI:10.1007/BF03350647
PMID:2985688
Abstract

The effect of ketanserin, a selective serotonin-2 (5-HT2) receptor blocking agent, on the secretion of anterior pituitary hormones was studied in 4 healthy volunteers. Ketanserin (10 mg) was administered as a slow iv injection and its effect was compared with that of saline. Ketanserin influenced neither the basal plasma levels of HGH, ACTH, TSH, LH or prolactin, nor the plasma levels of T4, T3, cortisol or glucose. Even if a single dose of ketanserin had no hormonal effects, this must also be studied after long term use.

摘要

在4名健康志愿者中研究了选择性5-羟色胺-2(5-HT2)受体阻断剂酮色林对垂体前叶激素分泌的影响。酮色林(10毫克)以缓慢静脉注射给药,并将其效果与生理盐水的效果进行比较。酮色林既不影响生长激素、促肾上腺皮质激素、促甲状腺激素、促黄体生成素或催乳素的基础血浆水平,也不影响甲状腺素、三碘甲状腺原氨酸、皮质醇或葡萄糖的血浆水平。即使单剂量的酮色林没有激素作用,长期使用后也必须对此进行研究。

相似文献

1
Ketanserin without effects on basal anterior pituitary hormone secretion in healthy subjects.酮色林对健康受试者的基础垂体前叶激素分泌无影响。
J Endocrinol Invest. 1985 Feb;8(1):73-5. doi: 10.1007/BF03350647.
2
The effect of ketanserin, a specific serotonin antagonist on the PRL, GH, ACTH and cortisol responses to hypoglycaemia in normal subjects.酮色林(一种特异性5-羟色胺拮抗剂)对正常受试者低血糖时催乳素、生长激素、促肾上腺皮质激素及皮质醇反应的影响。
Clin Endocrinol (Oxf). 1984 Feb;20(2):137-42. doi: 10.1111/j.1365-2265.1984.tb00068.x.
3
[Effect of subcutaneous injection of glucagon on secretion of anterior pituitary hormones].[皮下注射胰高血糖素对垂体前叶激素分泌的影响]
Horumon To Rinsho. 1975 Feb;23(2):141-5.
4
Multifactorial control of the 24-hour secretory profiles of pituitary hormones.
J Endocrinol Invest. 1985 Aug;8(4):381-91. doi: 10.1007/BF03348519.
5
The role of serotonin (5-HT) in the control of TSH and prolactin release in euthyroid subjects as assessed by the administration of ketanserin (5-HT2 antagonist) and zimelidine (5-HT re-uptake inhibitor).通过给予酮色林(5-羟色胺2拮抗剂)和齐美利定(5-羟色胺再摄取抑制剂)评估血清素(5-HT)在正常甲状腺功能受试者促甲状腺激素和催乳素释放控制中的作用。
Psychoneuroendocrinology. 1984;9(1):13-9. doi: 10.1016/0306-4530(84)90017-9.
6
Rapid sequential intravenous administration of four hypothalamic releasing hormones as a combined anterior pituitary function test in normal subjects.在正常受试者中,快速序贯静脉注射四种下丘脑释放激素作为联合垂体前叶功能试验。
J Clin Endocrinol Metab. 1985 Apr;60(4):623-30. doi: 10.1210/jcem-60-4-623.
7
On the effect of synthetic LH-releasing hormone on the blood levels of LH, FSH, HGH, TSH, ACTH, insulin and blood sugar in man.关于合成促黄体生成素释放激素对人体促黄体生成素、促卵泡生成素、生长激素、促甲状腺激素、促肾上腺皮质激素、胰岛素及血糖血浓度的影响。
Horm Metab Res. 1972 Sep;4(5):403. doi: 10.1055/s-0028-1097103.
8
[Effect of chronic administration of cimetidine on adenohypophysis secretion in children].
An Esp Pediatr. 1981 Feb;14(2):77-82.
9
Changes in anterior pituitary hormone levels after serotonin 1A receptor stimulation.血清素1A受体刺激后垂体前叶激素水平的变化。
Endocrinology. 1990 Aug;127(2):567-72. doi: 10.1210/endo-127-2-567.
10
The effect of electric convulsion therapy on the circulating concentrations of pituitary hormones, cortisol and cyclic adenosine monophosphate.
Clin Endocrinol (Oxf). 1976 Sep;5(5):571-4. doi: 10.1111/j.1365-2265.1976.tb01986.x.

引用本文的文献

1
Effects of ritanserin, a novel serotonin-S2 receptor antagonist, on the secretion of pituitary hormones in normal humans.新型5-羟色胺-S2受体拮抗剂利坦色林对正常人体内垂体激素分泌的影响。
J Endocrinol Invest. 1994 Jan;17(1):1-5. doi: 10.1007/BF03344953.

本文引用的文献

1
Two distinct central serotonin receptors with different physiological functions.两种具有不同生理功能的独特中枢5-羟色胺受体。
Science. 1981 May 15;212(4496):827-9. doi: 10.1126/science.7221567.
2
In vivo binding of [3H]ketanserin on serotonin S2-receptors in rat brain.[3H]酮色林在大鼠脑内对5-羟色胺S2受体的体内结合
Eur J Pharmacol. 1982 Jun 16;81(1):43-8. doi: 10.1016/0014-2999(82)90599-4.
3
The antihypertensive effects of ketanserin (R 41468), a novel 5-hydroxytryptamine-blocking agent, in patients with essential hypertension.
新型5-羟色胺阻断剂酮色林(R 41468)对原发性高血压患者的降压作用。
Clin Sci (Lond). 1981 Dec;61 Suppl 7:473s-476s. doi: 10.1042/cs061473s.
4
The antihypertensive effects of a pure and selective serotonin-receptor blocking agent (R 41 468) in elderly patients.一种纯的选择性血清素受体阻断剂(R 41 468)对老年患者的降压作用。
Angiology. 1981 Feb;32(2):137-44. doi: 10.1177/000331978103200206.
5
Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist.用新型选择性5-羟色胺2(5-HT2)受体拮抗剂酮色林治疗高血压。
Br Med J (Clin Res Ed). 1982 Feb 20;284(6315):537-9. doi: 10.1136/bmj.284.6315.537.
6
Effects of pirenperone and ketanserin on rat prolactin secretion in vivo and in vitro.匹仑哌隆和酮色林对大鼠体内外催乳素分泌的影响。
Eur J Pharmacol. 1983 Aug 19;92(1-2):83-9. doi: 10.1016/0014-2999(83)90111-5.
7
Characterization of the antihypertensive properties of ketanserin (R 41 468) in rats.酮色林(R 41 468)对大鼠降压特性的表征
J Pharmacol Exp Ther. 1982 Jul;222(1):227-31.
8
Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors.新型5-羟色胺2受体拮抗剂R 41 468的受体结合情况
Life Sci. 1981 Mar 2;28(9):1015-22. doi: 10.1016/0024-3205(81)90747-5.
9
Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors.酮色林(R 41 468)的血管效应,一种新型5-羟色胺2(5-HT2)血清素能受体拮抗剂。
J Pharmacol Exp Ther. 1981 Jul;218(1):217-30.
10
Acute blood-pressure-lowering effect of ketanserin.酮色林的急性降压作用。
Lancet. 1981 May 23;1(8230):1161-2. doi: 10.1016/s0140-6736(81)92331-x.